229 related articles for article (PubMed ID: 31790841)
1. Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review.
Newman S; Boulter JH; Malcolm JG; Pradilla I; Pradilla G
World Neurosurg; 2020 Mar; 135():165-170. PubMed ID: 31790841
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
[TBL] [Abstract][Full Text] [Related]
4. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
5. Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review.
Aguilar-Salinas P; Hayward K; Santos R; Agarwal V; Sauvageau E; Hanel RA; Aldana PR
World Neurosurg; 2019 Mar; 123():435-442.e8. PubMed ID: 30496928
[TBL] [Abstract][Full Text] [Related]
6. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
Aldana PR; Hanel RA; Piatt J; Han SH; Bansal MM; Schultz C; Gauger C; Pederson JM; Iii JCW; Hulbert ML; Jordan LC; Qureshi A; Garrity K; Robert AP; Hatem A; Stein J; Beydler E; Adelson PD; Greene S; Grabb P; Johnston J; Lang SS; Leonard J; Magge SN; Scott A; Shah S; Smith ER; Smith J; Strahle J; Vadivelu S; Webb J; Wrubel D
Pediatr Blood Cancer; 2023 Jul; 70(7):e30336. PubMed ID: 37057741
[TBL] [Abstract][Full Text] [Related]
7. Revascularization Is Associated With a Reduced Stroke Risk in Patients With Sickle Cell-Associated Moyamoya Syndrome.
Newman S; McMahon JT; Boulter JH; Malcolm JG; Revuelta Barbero JM; Chern JJ; Barrow DL; Pradilla G
Neurosurgery; 2022 Apr; 90(4):441-446. PubMed ID: 35132969
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
9. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
Smith ER; McClain CD; Heeney M; Scott RM
Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
[TBL] [Abstract][Full Text] [Related]
10. Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.
Hall EM; Leonard J; Smith JL; Guilliams KP; Binkley M; Fallon RJ; Hulbert ML
Pediatr Blood Cancer; 2016 Aug; 63(8):1431-7. PubMed ID: 27106860
[TBL] [Abstract][Full Text] [Related]
11. Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease: results of an individualized selection strategy.
Nielsen TH; Abhinav K; Sussman ES; Han SS; Weng Y; Bell-Stephens T; ; Heit JJ; Steinberg GK
J Neurosurg; 2020 Jun; 134(5):1578-1589. PubMed ID: 32534489
[TBL] [Abstract][Full Text] [Related]
12. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
13. Relative anemia and perioperative stroke in children with moyamoya.
Gatti JR; Ahmad SA; Gardner Yelton S; DiGiusto M; Leung D; Xu R; Cohen AR; Gottesman RF; Sun LR
J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107476. PubMed ID: 37976795
[TBL] [Abstract][Full Text] [Related]
14. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Surgical Treatment on the Recurrent Stroke Prevention for Adult Patients With Hemorrhagic Moyamoya Disease.
Wang G; Zhang X; Feng M; Liu X; Guo F
J Craniofac Surg; 2017 Nov; 28(8):2113-2116. PubMed ID: 29088693
[TBL] [Abstract][Full Text] [Related]
16. The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review.
Kazumata K; Ito M; Tokairin K; Ito Y; Houkin K; Nakayama N; Kuroda S; Ishikawa T; Kamiyama H
J Neurosurg; 2014 Aug; 121(2):432-40. PubMed ID: 24605834
[TBL] [Abstract][Full Text] [Related]
17. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome and moyamoya: clinical presentation and surgical management.
See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
[TBL] [Abstract][Full Text] [Related]
19. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.
Kennedy BC; McDowell MM; Yang PH; Wilson CM; Li S; Hankinson TC; Feldstein NA; Anderson RC
Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478
[TBL] [Abstract][Full Text] [Related]
20. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.
Fryer RH; Anderson RC; Chiriboga CA; Feldstein NA
Pediatr Neurol; 2003 Aug; 29(2):124-30. PubMed ID: 14580655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
